Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region
Tuesday, December 27, 2022Hikma Pharmaceuticals PLC Hikma the multinational pharmaceutical company today announces a new exclusive licensing and commercialization agreement with Junshi Biosciences an innovationdriven biopharmaceutical company for toripalimab in the Middle Eas...
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies
Tuesday, December 27, 2022Ablaze Pharmaceuticals announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co Ltd Yonghe to develop series of targeted radiopharmaceutical therapy TRT products Under the agreement Yongh...
Lilly and ProQR to Expand RNA Editing Collaboration
Friday, December 23, 2022Eli Lilly and Company and ProQR Therapeutics NV today announced the expansion of their licensing and collaboration agreement focused on the discovery development and commercialization of new genetic medicines The collaboration originally announced in...
Merck Announces Collaboration With Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates
Friday, December 23, 2022Merck a leading science and technology company today announced a research collaboration and commercial license agreement with Mersana Therapeutics Inc Cambridge Massachusetts USA to discover novel antibodydrug conjugates ADCs leveraging Mersanas prop...
Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses
Thursday, December 22, 2022Ethris GmbH a leading biotechnology company pioneering nextgeneration messenger RNA mRNA therapeutics and vaccines announced today a collaboration with UKbased DIOSynVax to jointly develop a protective mRNA vaccine candidate against a broad range of...
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
Thursday, December 22, 2022Berkeley Lights a life sciences tools company and IsoPlexis Nasdaq ISO a company empowering labs to leverage the cells and proteome changing the course of human health today announced a definitive agreement under which Berkeley Lights will acquire Is...
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
Wednesday, December 21, 2022Kite a Gilead Company and Tmunity Therapeutics Tmunity today announced that the companies have signed an agreement in which Kite will acquire Tmunity a clinicalstage private biotech company focused on nextgeneration CAR Ttherapies and technologies Th...
Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE
Wednesday, December 21, 2022Skye Bioscience Inc a pharmaceutical company developing a proprietary synthetic cannabinoid derivative to treat glaucoma today announced that the US Food and Drug Administration FDA has given the okay to proceed for the Investigational New Drug IND a...
Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology
Tuesday, December 20, 2022Sanofi and Innate Pharma SA announced today an expansion of their collaboration with Sanofi licensing a natural killer NK cell engager program targeting BH from Innates ANKETTM Antibodybased NK Cell Engager Therapeutics platform Sanofi will also have...
Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc
Tuesday, December 20, 2022Bioasis Technologies Inc a multiasset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and a differentiated proprietary xB platform for delivering therapeutics across the bloodbra...
